
Japan Tobacco International's Canadian subsidiary, JTI-Macdonald Corp, has rejected an arbitration proposal worth 32.5 billion Canadian dollars (23.3 billion U.S. dollars), according to an October 31 Barrons report.
The arbitration proposal is aimed at resolving legal disputes stemming from the harm caused by cigarettes, but the company has expressed dissatisfaction and rejected the proposal. Currently, the company is still engaged in complex legal negotiations with provincial governments and smokers.
In documents filed with the Ontario Superior Court of Justice before the hearing, the company stated that it is unable to support the agreement due to "key unresolved issues." These issues include the settlement amount and how payments will be distributed among multinational companies.
The company stated in court documents that, "This agreement may introduce significant commercial uncertainty and ambiguity in the settlement application of the Canadian tobacco industry. Therefore, JTI-Macdonald and its tobacco company group will not support the current form of the arbitration plan."
According to the terms of the agreement, several tobacco companies will pay a total of $32.5 billion Canadian dollars (US$23.3 billion) to settle litigation in Canada.
These companies include Philip Morris International (PMI) Canada subsidiary, British American Tobacco (BAT) Canada subsidiary, Imperial Tobacco Canada subsidiary (IMB), and Japan Tobacco International (JTI).
The arbitration announced on October 17 will put an end to all claims related to the manufacturing, marketing, selling, using, or handling of tobacco products by these companies. Class action lawsuits against these companies and legal efforts by Canadian provinces to recover medical costs will also be dismissed.
The case began in June 2015 when the Quebec Superior Court ordered these three manufacturers to pay billions of dollars in compensation to thousands of Quebec tobacco victims, including smokers or former smokers suffering from emphysema, lung cancer, or throat cancer. In 2019, the ruling was upheld on appeal, prompting the companies to seek creditor protection. Subsequently, a court in Ontario suspended legal proceedings as parties sought to negotiate a settlement.
On Thursday, the Ontario Superior Court extended the stay of proceedings until January 31, 2025.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com